UNASSIGNED: This retrospective cohort study included 210 patients who underwent endovascular treatment for symptomatic AIOD between January 2010 and December 2020. The patients\' clinical and lesion characteristics, including technical considerations of the procedure, were collected, analyzed, and stratified using the Transatlantic Inter-Society Consensus (TASC).
UNASSIGNED: Most patients (80%) in this study had chronic limb-threatening ischemia lesions, with an occlusion rate of 37%. The technical success rate of TASC C & D was lower than that of TASC A & B, 84.4% vs. 99.2% p ≤ 0.001. A technical success rate of 93.3% (14/15) was found for the femoral and brachial approach, compared with a success rate of 89.0% (57/64) for the unibifemoral approach in TASC C & D, without a statistically significant difference (p = 0.076). However, the puncture site complications in this route were up to 17.6%, which is the highest rate compared with other techniques. These complications could be treated either conservatively or minimally invasively.
UNASSIGNED: In cases of failed femoral access, simultaneous femoral and brachial approaches improved the technical success rate of endovascular recanalization of TASC C & D aortoiliac occlusions.
这项回顾性队列研究纳入了2010年1月至2020年12月期间接受有症状AIOD血管内治疗的210例患者。患者的临床和病变特征,包括程序的技术考虑,被收集,分析,并使用跨大西洋社会间共识(TASC)进行分层。
■这项研究中的大多数患者(80%)患有慢性威胁肢体的缺血病变,闭塞率为37%。TASCC&D的技术成功率低于TASCA&B,84.4%vs.99.2%p≤0.001。股骨和肱入路的技术成功率为93.3%(14/15),与TASCC&D中单声入路的89.0%(57/64)的成功率相比,无统计学差异(p=0.076)。然而,该途径的穿刺部位并发症高达17.6%,与其他技术相比,这是最高的比率。这些并发症可以保守或微创治疗。
■在股骨入路失败的情况下,股动脉和肱动脉同时入路提高了TASCC&D主髂动脉闭塞血管内再通的技术成功率。